Sarah Inglott

3.0k total citations
15 papers, 237 citations indexed

About

Sarah Inglott is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Immunology. According to data from OpenAlex, Sarah Inglott has authored 15 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 9 papers in Hematology and 4 papers in Immunology. Recurrent topics in Sarah Inglott's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sarah Inglott is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sarah Inglott collaborates with scholars based in United Kingdom, United States and Australia. Sarah Inglott's co-authors include Jack Bartram, Owen Williams, Csaba Bödör, Robert K. Hills, David C. Linch, John Anderson, Phil Ancliff, Jude Fitzgibbon, Rosemary E. Gale and Alan K. Burnett and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sarah Inglott

14 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Inglott United Kingdom 9 100 99 92 74 48 15 237
Heather Ogana United States 7 87 0.9× 66 0.7× 66 0.7× 60 0.8× 34 0.7× 16 204
Alex Elder United Kingdom 5 121 1.2× 58 0.6× 64 0.7× 63 0.9× 46 1.0× 12 207
Pierre Walrafen France 4 95 0.9× 37 0.4× 140 1.5× 71 1.0× 21 0.4× 5 248
Marissa Rashkovan Canada 6 107 1.1× 31 0.3× 119 1.3× 42 0.6× 55 1.1× 7 210
Kyogo Suzuki Japan 6 69 0.7× 185 1.9× 167 1.8× 31 0.4× 80 1.7× 15 333
Daniel Ribeiro Portugal 7 74 0.7× 81 0.8× 114 1.2× 94 1.3× 77 1.6× 10 260
Ilan Kirsch United States 5 100 1.0× 133 1.3× 45 0.5× 111 1.5× 10 0.2× 11 257
Bert van der Reijden Netherlands 7 182 1.8× 71 0.7× 201 2.2× 27 0.4× 54 1.1× 13 314
Maria Laura Milani Italy 6 118 1.2× 176 1.8× 75 0.8× 118 1.6× 88 1.8× 11 326
Patricia Steinert United States 6 87 0.9× 178 1.8× 48 0.5× 37 0.5× 32 0.7× 19 250

Countries citing papers authored by Sarah Inglott

Since Specialization
Citations

This map shows the geographic impact of Sarah Inglott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Inglott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Inglott more than expected).

Fields of papers citing papers by Sarah Inglott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Inglott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Inglott. The network helps show where Sarah Inglott may publish in the future.

Co-authorship network of co-authors of Sarah Inglott

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Inglott. A scholar is included among the top collaborators of Sarah Inglott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Inglott. Sarah Inglott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
O’Connor, David, Jonas Demeulemeester, Lucía Conde, et al.. (2023). The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 41(19). 3545–3556. 12 indexed citations
2.
Gasparoli, Luca, Clémence Virely, Sandra Cantilena, et al.. (2022). Identification of a c-MYB-directed therapeutic for acute myeloid leukemia. Leukemia. 36(6). 1541–1549. 19 indexed citations
3.
Khabirova, Eleonora, Laura Jardine, Tim Coorens, et al.. (2022). Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia. Nature Medicine. 28(4). 743–751. 39 indexed citations
4.
O’Connor, David, Jonas Demeulemeester, Lucía Conde, et al.. (2022). The Clinico-Genomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 140(Supplement 1). 1720–1721.
5.
Rice, Siobhan, Thomas Jackson, Nicholas T. Crump, et al.. (2021). A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nature Communications. 12(1). 6905–6905. 28 indexed citations
6.
Bartram, Jack, Gary Wright, Stuart Adams, et al.. (2021). High‐throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B‐cell acute lymphoblastic leukemia: A prospective feasibility study. Pediatric Blood & Cancer. 69(3). e29513–e29513. 5 indexed citations
7.
Ottaviano, Giorgio, Christos Georgiadis, Farhatullah Syed, et al.. (2021). TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL. Blood. 138(Supplement 1). 4838–4838. 4 indexed citations
8.
Virely, Clémence, Luca Gasparoli, Sarah Inglott, et al.. (2020). ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)‐Associated Acute Lymphoblastic Leukemia. HemaSphere. 4(5). e467–e467. 1 indexed citations
9.
Inglott, Sarah, Philip Ancliff, Jack Bartram, et al.. (2020). CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy. Blood Advances. 4(19). 4665–4668. 12 indexed citations
10.
Fisher, Jonathan, Roshan Sharma, Marta Barisa, et al.. (2019). Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors. Science Signaling. 12(598). 40 indexed citations
11.
Wright, Gary, et al.. (2019). Clinical benefit of a high‐throughput sequencing approach for minimal residual disease in acute lymphoblastic leukemia. Pediatric Blood & Cancer. 66(8). e27787–e27787. 7 indexed citations
12.
Straathof, Karin, Barry Flutter, Rebecca Wallace, et al.. (2018). Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma. Cancer Research. 78(13_Supplement). CT145–CT145. 19 indexed citations
13.
Stasevich, Irina, Sarah Inglott, Jane Chalker, et al.. (2015). PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 171(2). 263–272. 12 indexed citations
14.
Roy, Anindita, Georg Bohn, Katerina Goudevenou, et al.. (2014). Developmental Stage Specific B-Progenitor Expansion in Normal Fetal Bone Marrow Is Absent in Down Syndrome: Implications for Infant ALL. Blood. 124(21). 4331–4331. 1 indexed citations
15.
Green, Claire L., Kiran Tawana, Robert K. Hills, et al.. (2013). GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations. British Journal of Haematology. 161(5). 701–705. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Ogana Breakdown of academic impact, for papers by Alex Elder Breakdown of academic impact, for papers by Pierre Walrafen Breakdown of academic impact, for papers by Marissa Rashkovan Breakdown of academic impact, for papers by Kyogo Suzuki Breakdown of academic impact, for papers by Daniel Ribeiro Breakdown of academic impact, for papers by Ilan Kirsch Breakdown of academic impact, for papers by Bert van der Reijden Breakdown of academic impact, for papers by Maria Laura Milani Breakdown of academic impact, for papers by Patricia Steinert
Rankless by CCL
2026